These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22156787)

  • 1. Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report.
    Dunaway S; Montes J; Ryan PA; Montgomery M; Sproule DM; De Vivo DC
    J Child Neurol; 2012 Jun; 27(6):779-85. PubMed ID: 22156787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
    Nelson L; Owens H; Hynan LS; Iannaccone ST;
    Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.
    Werlauff U; Vissing J; Steffensen BF
    Neuromuscul Disord; 2012 Dec; 22(12):1069-74. PubMed ID: 23127961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.
    Deymeer F; Serdaroglu P; Parman Y; Poda M
    Neurology; 2008 Aug; 71(9):644-9. PubMed ID: 18725590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.
    Kroksmark AK; Beckung E; Tulinius M
    Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III.
    Madsen KL; Hansen RS; Preisler N; Thøgersen F; Berthelsen MP; Vissing J
    Muscle Nerve; 2015 Aug; 52(2):240-4. PubMed ID: 25418505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disordered breathing in spinal muscular atrophy.
    Mellies U; Dohna-Schwake C; Stehling F; Voit T
    Neuromuscul Disord; 2004 Dec; 14(12):797-803. PubMed ID: 15564035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease).
    Kang PB; Krishnamoorthy KS; Jones RM; Shapiro FD; Darras BT
    Neuromuscul Disord; 2006 Aug; 16(8):492-4. PubMed ID: 16797181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing natural history of spinal muscular atrophy type 1.
    Oskoui M; Levy G; Garland CJ; Gray JM; O'Hagen J; De Vivo DC; Kaufmann P
    Neurology; 2007 Nov; 69(20):1931-6. PubMed ID: 17998484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of 4 outcome measures in pediatric spinal muscular atrophy.
    Iannaccone ST; Hynan LS;
    Arch Neurol; 2003 Aug; 60(8):1130-6. PubMed ID: 12925371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I.
    Finkel RS
    Neuromuscul Disord; 2013 Feb; 23(2):112-5. PubMed ID: 23146148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of motor control in patients with proximal childhood spinal muscle atrophy (pilot study).
    Bojakowski J; Dimitrijevic MR; Hausmanowa-Petrusewicz I; Sherwood AM; Wawro AW; Zalewska E
    Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):375-83. PubMed ID: 8223338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquatic therapy for a child with type III spinal muscular atrophy: a case report.
    Salem Y; Gropack SJ
    Phys Occup Ther Pediatr; 2010 Nov; 30(4):313-24. PubMed ID: 20868338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spinal muscular atrophy. A 4-year prospective, multicenter, longitudinal study (168 cases)].
    Barois A; Mayer M; Desguerre I; Chabrol B; Berard C; Cuisset JM; Leclair-Richard D; Visconti-Lougovoy J; Hatton F; Estournet-Mathiaud B
    Bull Acad Natl Med; 2005 Jun; 189(6):1181-98; discussion 1198-9. PubMed ID: 16433443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle strength and motor function in adolescents and adults with spinal muscular atrophy.
    Wijngaarde CA; Stam M; Otto LAM; Bartels B; Asselman FL; van Eijk RPA; van den Berg LH; Goedee HS; Wadman RI; van der Pol WL
    Neurology; 2020 Oct; 95(14):e1988-e1998. PubMed ID: 32732299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients.
    Werlauff U; Steffensen BF; Bertelsen S; Fløytrup I; Kristensen B; Werge B
    Neuromuscul Disord; 2010 Jan; 20(1):34-43. PubMed ID: 19969460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.